Related Experiment Video
Updated: Dec 20, 2025

08:43
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
8.3K
White Matter Brain Network Research in Alzheimer's Disease Using Persistent Features.
Liqun Kuang1, Yan Gao1, Zhongyu Chen1
1School of Data Science and Technology, North University of China, Taiyuan 030051, China.
Molecules (Basel, Switzerland)
|May 31, 2020
Summary
Persistent homology reveals altered brain networks in Alzheimer's disease (AD) and mild cognitive impairment (MCI). This advanced topological analysis offers a more sensitive method for detecting brain changes than traditional measures, aiding in understanding AD progression.
Area of Science:
- Neuroscience
- Medical Imaging
- Network Science
Background:
- Alzheimer's disease (AD) poses a significant social burden, yet effective disease-modifying drugs are lacking.
- Structural brain network analysis offers insights into the physiological changes associated with AD and its precursor, mild cognitive impairment (MCI).
- Persistent homology is an emerging tool for studying brain network dynamics and global organization, but its application to AD/MCI structural networks requires further investigation.
Purpose of the Study:
- To investigate how persistent homology measures reflect topological changes in white matter (WM) networks of individuals with AD and MCI.
- To compare the efficacy of persistent homology-based measures against traditional graph-theoretical measures in detecting network alterations in AD and MCI.
- To assess the potential of these topological measures for tracking AD progression.
Main Methods:
- Utilized diffusion tensor imaging (DTI) to construct WM networks from 150 subjects (AD, MCI, and normal controls - NC).
- Quantified network topology using previously developed persistent homology features and standard graph-theoretical metrics.
- Analyzed network properties across different brain parcellation schemes.
Main Results:
- Significant differences in topological network measures were observed among AD, MCI, and NC groups.
- Both AD and MCI groups exhibited decreased network integration and increased network segregation compared to NC.
- Persistent homology measures demonstrated superior statistical power and robustness over traditional graph-theoretic approaches.
Conclusions:
- Persistent homology provides a more sensitive method for detecting structural brain network alterations in AD and MCI.
- These findings enhance the understanding of the structural connectome in AD and offer a novel approach for monitoring disease progression.
- The study highlights the potential of advanced topological methods in neurodegenerative disease research.
Related Concept Videos
Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Alzheimer's Disease: Treatment
680
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
680

